Sulphasalazine-induced aseptic meningitis with facial and nuchal edema in a patient with spondyloarthritis.
Sen Hee
SH
Tay
Aisha
A
Lateef
Peter P
PP
Cheung
D000212:Acyclovir / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D004487:Edema / Q000139:chemically induced* / Q000473:pathology; D005145:Face; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use; D007275:Injections, Intravenous; D008582:Meningitis, Aseptic / Q000139:chemically induced* / Q000473:pathology; D008875:Middle Aged; D009333:Neck; D011239:Prednisolone / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000150:complications* / Q000188:drug therapy; D012460:Sulfasalazine / Q000009:adverse effects*; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D018501:Antirheumatic Agents; D000998:Antiviral Agents; D005938:Glucocorticoids; D012460:Sulfasalazine; D011239:Prednisolone; D006854:Hydrocortisone; D000212:Acyclovir